A phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory metastatic colorectal cancer. Background: MicroRNAs (miR) are small non-coding ...
VEDBAEK, Denmark, Dec. 6, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 6th generation of ...
DUBLIN, Aug. 18, 2020 /PRNewswire/ -- The "Global miRNA Sequencing and Assay Market - Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback